FDA Adverse Event Injury Summary report: N

OT ULTRAMINI METER

MDR report key: 3160974 · Received June 11, 2013

Report

Report Number
3008382007-2013-16387
Event Type
Injury
Date Received
June 11, 2013
Report Date
May 23, 2013
Manufacturer
LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL
Product Code
NBW
PMA / PMN Number
K061118
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MT, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

LIFESCAN (LFS) HAS REQUESTED RETURN OF THE SUBJECT PRODUCT(S) FOR EVALUATION. IF THE PRODUCT(S) ARE RETURNED, LFS WILL EVALUATE IT/THEM AND INFORM FDA OF PRODUCT(S) THAT DO NOT PASS INSPECTION IN A SUPPLEMENTAL REPORT.

Description of Event or Problem · 1

ON (B)(6) 2013 THE LAY USER/ PATIENT CONTACTED LIFESCAN (LFS) ALLEGING HER ONETOUCH ULTRAMINI METER HAD BLACK MARKS ON THE DISPLAY. THE COMPLAINT WAS CLASSIFIED BASED ON THE CUSTOMER CARE ADVOCATE (CCA) DOCUMENTATION. THE PATIENT WAS UNABLE TO RECALL WHEN THE ALLEGED ISSUE FIRST STARTED. THE PATIENT REPORTED USING SELF ADJUSTING INSULIN TO MANAGE HER DIABETES. THE PATIENT REPORTED ON AN UNKNOWN DATE AND TIME SHE EXERCISED IN RESPONSE TO THE ALLEGED ISSUE. THE PATIENT REPORTED DEVELOPING SYMPTOMS OF ¿HIGH BLOOD GLUCOSE¿ 24 HOURS AFTER THE ALLEGED ISSUE OCCURRED. THE PATIENT REPORTED ON AN UNKNOWN DATE AND TIME SHE WAS TREATED IN THE EMERGENCY ROOM OR HOSPITAL FOR A BLOOD GLUCOSE OF ¿ 713 MG/DL¿ WITH INSULIN. AT THE TIME OF TROUBLESHOOTING, THE CCA WAS ABLE TO DETERMINE THIS WAS NOT THE FIRST TIME THE METER HAD BEEN USED, AND THERE WAS NO MISUSE OF THE PRODUCT. REPLACEMENT PRODUCTS WERE SENT. THIS COMPLAINT IS BEING REPORTED AS AN ADVERSE EVENT SINCE THE PATIENT CLAIMS, DUE TO THE ALLEGED ISSUE, WAS UNABLE TO TEST AND THEREFORE DEVELOPED EXTREMELY HIGH BLOOD GLUCOSE AND REQUIRED TREATMENT FROM A HEALTH CARE PROFESSIONAL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
262687 OT ULTRAMINI METER GLUCOSE MONITORING SYS/KIT NBW LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL 3357278

Patients

Seq Age Sex Outcome Treatment
1 31 YR Hospitalization| L| R